目的:研究分析舒利迭治疗慢性阻塞性肺疾病(COPD)合并陈旧性肺结核临床治疗效果,为临床治疗和理论研究提供临床依据。方法:将我院2011年2月~2012年2月期间收治的69例COPD合并陈旧性肺结核患者的临床资料进行回顾性分析,分为两组,观察组患者35例,对照组患者34例。针对观察组患者在常规治疗基础上使用舒利迭治疗,对照组患者使用常规治疗方法进行治疗,比较分析两组患者疗效。结果:经过治疗,两组患者半年急性发作次数及住院时间比较,观察组均显著少于对照组,组间差异明显,P<0.05差异具有统计学意义。在治疗期间,两组患者均未见严重的不良反应(P>0.05)。结论:舒利迭治疗COPD合并陈旧性肺结核安全、有效,值得在临床上推广使用。 Objective: To study and analyze the effect of seretide on clinical treatment of chronic obstructive pulmonary disease (COPD) complicated with old pulmonary tuberculosis, and to provide clinical evidence for clinical treatment and theoretical study. Methods: The clinical data of 69 patients with chronic obstructive pulmonary disease from our hospital from February 2011 to February 2012 were retrospectively analyzed. There were 35 patients in the observation group and 34 in the control group. Patients in the observation group were treated with seretide on the basis of routine treatment, while patients in the control group were treated by conventional therapy. The curative effect of the two groups was compared and analyzed. Results: After treatment, the number of acute exacerbations and hospital stay in both groups were significantly less than those in the control group. There was significant difference between the two groups. P <0.05 was considered as statistically significant. During the treatment, no serious adverse reactions were found in both groups (P> 0.05). Conclusion: Seretide treatment of COPD with old tuberculosis is safe and effective, which is worth to be popularized clinically.